Relmada Therapeutics, Inc. (RLMD)

Unlocking life changing therapies

News

View all news

News - Nov 13, 2025

Relmada Therapeutics Reports Third Quarter 2025 Financial Results and Provides Key Clinical, Regulatory, and Corporate Updates

News - Nov 7, 2025

Relmada Therapeutics to Report Third Quarter 2025 Financial Results on Thursday, November 13, 2025

News - Nov 4, 2025

Relmada Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

Events

View all events

Event - Nov 13, 2025 4:30 PM EST

Q3 2025 Financial Results Conference Call

Read more

Event - Aug 7, 2025 4:30 PM EST

Q2 2025 Financial Results Conference Call

Read more

Event - May 23, 2025 9:30 AM EST

2025 Annual Meeting of Stockholders

Read more

Company